XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) Q1 2026 Earnings

XRTX·Reported May 15, 2026·After market close

Diluted EPS came in at $-0.58 (-205.3% YoY).

Diluted EPS
$-0.58
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet

Filings will appear here once submitted to SEC EDGAR.

Q1 2026 Earnings FAQ

Common questions about XORTX Therapeutics Inc.'s Q1 2026 earnings report.

XORTX Therapeutics Inc. (XRTX) reported Q1 2026 earnings on May 15, 2026 after market close.

XORTX Therapeutics Inc. reported diluted EPS of $-0.58 for Q1 2026.

Compared to the same quarter a year prior, diluted EPS declined 205.3% from $-0.19.